News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ProstateCancer’ clear

  • Dr. Philip Kantoff says the United States Preventive Services Task Force's conclusion that prostate-specific antigen (PSA) testing provides limited value is the wrong message.

Tags: ProstateCancer

  • New research from the Dana-Farber/Brigham and Women's Cancer Center shows that newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002–2005 without proof of their cost-effectiveness.

Tags: ProstateCancer

  • Researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease.

Tags: Genomics, ProstateCancer

  • Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, Dana-Farber Cancer Institute researchers report in an online study published by the journal Nature.

Tags: ProstateCancer, Genetics

  • Analysis finds higher quality of life for men diagnosed with low-risk prostate cancer who choose ongoing exams over immediate treatment.

Tags: ProstateCancer

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch, Immunotherapy

  • The vaccine, which contained weakened poxviruses genetically programmed to spur an immune system attack on prostate tumor cells, helped patients lived longer than patients who received a placebo vaccine.

Tags: ProstateCancer, TranslationalResearch

  • Nine-fold higher pancreatic cancer risk suggests people with this genetic syndrome should be closely monitored.

Tags: ProstateCancer, Genetics

  • Deprived of androgen hormones, the receptor finds an alternative genetic pathway to continue growth of prostate cancer cells. An understanding of this behavior could lead to new therapies targeting specific genes.

Tags: BasicResearch, ProstateCancer, Genetics

  • In prostate cancer patients with a certain genetic variant, a high level of selenium in the blood was associated with a two-fold greater risk of poorer outcomes than men with the lowest amounts of selenium.

Tags: BasicResearch, ProstateCancer

Showing 11-20 of 23 items